RECOFOL ® propofol satisfying anaesthesia & ICU sedation

RECOFOL – 1st branded generic propofol acquired from Bayer in 2011

  • intravenous anaesthetic, which is used by intensive care units, surgeries and clinics. RECOFOL can be used from light sedation to total anaesthesia
  • RECOFOL active ingredient is propofol, which is the most widely used intravenous anaesthetic with growing global demand
  • Primex are expanding RECOFOL geographically with regional partners

RECOFOL N

Recofol N is a Bayer-originated intravenous anaesthetic, which is used by intensive care units, surgeries and clinics.

Primex Pharmaceuticals obtained Recofol N through an acquisition from Bayer in 2012. Recofol N’s active ingredient is propofol.

Recofol N is manufactured in Europe.

Primex-recofol
News 1

Recofol EDTA

Recofol EDTA (propofol plus EDTA) is propofol with the preservative EDTA as an antimicrobial retardant,  as required by the FDA and other authorities and is manufactured in EU.